Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients

被引:34
|
作者
Madden, RL [1 ]
Mulhern, JG [1 ]
Benedetto, BJ [1 ]
O'Shea, MH [1 ]
Germain, MJ [1 ]
Braden, GL [1 ]
O'Shaughnessy, J [1 ]
Lipkowitz, GS [1 ]
机构
[1] Tufts Univ, Sch Med, Baystate Med Ctr, Dept Surg,Div Transplantat, Springfield, MA 01199 USA
关键词
renal transplantation; acute rejection; chronic rejection;
D O I
10.1111/j.1432-2277.2000.tb01008.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Although acute rejection (AR) has been shown to correlate with decreased long-term renal allograft survival, we have noted AR in recipients who subsequently had stable function for more than 5 years. We reviewed 109 renal graft recipients with a minimum of 1 year graft survival and follow-up of 5-8 years. Post-transplant sodium iothalamate clearances (IoCl) measured at 3 months and yearly thereafter were used to separate recipients into 2 groups. Ln 61 patients (stable group), there was no significant decrease ( > 20 % reduction in IoCl over 2 consecutive years) in IoCl. Forty-eight patients had significant declines in IoCl (decline group). Groups were compared for incidence, severity, timing, and completeness of reversal of AR. Rejection was considered completely reversed if the post-AR serum creatinine (Scr) returned to or below the pre-AR nadir Scr after antirejection therapy. The incidence of AR was not significantly different between groups (47 % vs 52 %). A trend toward a lower mean number of AR episodes per patient was noted in the stable group (0.69 vs 1.04, P = 0.096), but the timing of AR was not different. Steroid-resistant AR occurred in approximately 25 % of both groups. A striking difference was seen in complete reversal of AR, with the stable group having 100 % (42/42 episodes of AR in 29 patients) complete reversal whereas only 32 % (8/25) of the patients in the decline group had complete reversal (P < < 0.001). Of 8 declining patients with complete reversal, graft loss was due to chronic rejection (CR) in only 3. Seventeen declining patients had incomplete reversal of AR, and 82 % (14/17) lost their grafts to CR. Overall, only 8 % (3/37) of the recipients with complete reversal of AR developed CR. No patients with incompletely reversed BR had stable long-term function as measured by IoCl. AR is not invariably deleterious to longterm renal graft function if each episode of AR can be completely reversed.
引用
收藏
页码:344 / 350
页数:7
相关论文
共 50 条
  • [41] Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection
    Weber, LT
    Armstrong, VW
    Shipkova, M
    Feneberg, R
    Wiesel, M
    Mehls, O
    Zimmerhackl, LB
    Oellerich, M
    Tönshoff, B
    THERAPEUTIC DRUG MONITORING, 2004, 26 (04) : 415 - 424
  • [42] Sonographic and scintigraphic evaluation of acute renal allograft rejection in cats
    Halling, KB
    Graham, JP
    Newell, SP
    Ellison, GW
    Detrisac, CJ
    Martin, FG
    VanGilder, JM
    Grossman, D
    VETERINARY RADIOLOGY & ULTRASOUND, 2003, 44 (06) : 707 - 713
  • [43] Risk factors for acute rejection in renal transplant recipients experiencing delayed graft function
    Moore, Jason
    Tan, Kay
    Cockwell, Paul
    Krishnan, Hari
    McPake, Dawn
    Ready, Andrew
    Mellor, Steve
    Hamsho, Ahmed
    Ball, Simon
    Lipkin, Graham
    Borrows, Richard
    CLINICAL TRANSPLANTATION, 2008, 22 (05) : 634 - 638
  • [44] Pentraxin-3 expression in acute renal allograft rejection
    Imai, Naofumi
    Nishi, Shinichi
    Yoshita, Kazuhiro
    Ito, Yumi
    Osawa, Yutaka
    Takahashi, Kaori
    Nakagawa, Yuki
    Saito, Kazuhide
    Takahashi, Kota
    Narita, Ichiei
    CLINICAL TRANSPLANTATION, 2012, 26 : 25 - 31
  • [45] Tumour necrosis factor levels during acute rejection and acute tubular necrosis in renal transplant recipients
    Wiggins, MC
    Bracher, M
    Mall, A
    Hickman, R
    Robson, SC
    Kahn, D
    TRANSPLANT IMMUNOLOGY, 2000, 8 (03) : 211 - 215
  • [46] New approaches to the management of acute and chronic cardiac allograft rejection
    Isobe, M
    Suzuki, J
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1998, 62 (05): : 315 - 327
  • [47] Serum neopterin as an indicator of increased risk of renal allograft rejection
    Carey, B. Sean
    Jain, Rashmi
    Adams, Claire L.
    Wong, Kam Yim
    Shaw, Steve
    Tse, Wai Yee
    Kaminski, Edward R.
    TRANSPLANT IMMUNOLOGY, 2013, 28 (2-3) : 81 - 85
  • [48] AN ANALYSIS OF CYTOKINE GENE POLYMORPHISMS ON ACUTE REJECTION IN RENAL RECIPIENTS
    Wan, Qiquan
    wu, Di
    Xiao, Xiuzhen
    ACTA MEDICA MEDITERRANEA, 2018, 34 (01): : 47 - 50
  • [49] A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients
    Mohammad Hossein Karimi
    Saeed Daneshmandi
    Ali Akbar Pourfathollah
    Bita Geramizadeh
    Ramin Yaghobi
    Ghanbar Ali Rais-Jalali
    Jamshid Roozbeh
    Shahram Bolandparvaz
    Molecular Biology Reports, 2012, 39 : 509 - 515
  • [50] Association of Donor Vascular Endothelial Growth Factor Gene Polymorphism With Acute Renal Allograft Rejection
    Prasad, Narayan
    Yadav, Brijesh
    Bhatt, Mansi
    Chauhan, Ranjeet
    Agrawal, Vinita
    CLINICAL TRANSPLANTATION, 2024, 38 (10)